• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Significant mortality rate variation associated with race in the United States

byJack LennonandAlex Chan
October 26, 2020
in Infectious Disease, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Age-specific mortality rates varied significantly by race in the context of COVID-19 infection.

2. Higher mortality rates were observed for Blacks, Hispanics, American Indians, and Asians, relative to Whites.

Evidence Rating Level: 3 (Average)

The United States has faced the omnipresent reality of racial health disparities, with COVID-19 opening the door to bring these issues to the forefront. Non-Hispanic White individuals are being impacted at a significantly reduced rate compared to underrepresented minorities. This cross-sectional study drew data from the US Census between February 1, 2020 and July 22, 2020 to investigate age-specific variations in COVID-19 mortality rates stratified by racial group. The number of deaths related to COVID-19 by race were 68,377 for Whites, 29,476 for Blacks, 23,256 for Hispanics, 1,143 for American Indians/Alaskan Natives, and 6,468 for Asians/Pacific Islanders. Relative to White individuals, the age-standardized rate ratios were calculated for Blacks (RR = 3.6, 95% CI 3.5 to 3.8, p<.001), Hispanics (RR = 2.8, 95% CI 2.7 to 3.0, p<.001), American Indians/Alaskan Natives (RR = 2.2, 95% CI 1.8 to 2.6, p<.001), and Asians/Pacific Islanders (RR = 1.6, 95% CI 1.4 to 1.7, p<.001). For persons between the ages of 35 and 44 years, rate ratios relative to Whites were quite high, with Blacks being 9.0 (95% CI 7.9 to 10.0, p<.001) and Hispanics being 7.0 (95% CI 5.8 to 8.7, p<.001). American Indians/Alaskan Natives demonstrated similarly high rate ratios through 74 years of age. Age-standardized rates alone would not result in these findings. However, this study suggests that there is substantial variation by race in age-specific mortality rates amidst COVID-19. Further research should exercise caution in the use of age standardization when working within age strata.

Click to read the study in PLOS Medicine

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

BNT162b2 safe and efficacious in children 5 to 11 years of age

Tags: SARS-CoV-2social determinants of health
Previous Post

2 Minute Medicine Rewind October 26, 2020

Next Post

Evolocumab successfully reduced LDL levels in pediatric patients

RelatedReports

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

May 13, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

May 13, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

BNT162b2 safe and efficacious in children 5 to 11 years of age

May 13, 2022
Masks for personal protection for SARS-CoV-2 infection
Chronic Disease

Adding mask recommendation did not significantly reduce the SARS-CoV-2 infection rate

May 13, 2022
Next Post
Febuxostat not effective at delaying progression of carotid atherosclerosis in asymptomatic hyperuricemia

Evolocumab successfully reduced LDL levels in pediatric patients

#VisualAbstract: Drug-eluting stents for saphenous vein grafts associated with better outcomes than bare-metal stents

#VisualAbstract: Outcomes of COVID-19-related ARDS patients on extracorporeal membrane oxygenation

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

Altered acylcarnitine metabolism associated with increased risk of atrial fibrillation

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
  • #VisualAbstract: Ruxolitinib shows long-term safety and efficacy in inadequately controlled polycythaemia vera without splenomegaly
  • Wellness Check: Sleep
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.